HRAS and melanoma: In melanoma, James et al., Iwei et al., and Thomas et al. thought that fusion proteins and most common oncogenic drivers such as BRAF, NRAS and HRAS are mutually exclusive, so that NTRK fusion proteins might be more common in BRAF or NRAS wild-type melanoma (91–93).